PPARG and breast carcinoma: The interaction between PPARγ and mTOR has been particularly well demonstrated in mouse models of breast cancer, in which the activation of PPARγ led to rapamycin resistance, whereas rapamycin treatment triggered both the expression and activation of PPARγ [247].